Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Wiendl, H; Bourdette, D; Ciccarelli, O; (2017) Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis? [Editorial comment]. Neurology , 89 (11) pp. 1098-1100. 10.1212/WNL.0000000000004381. Green open access

Preview

Text
Ciccarelli_1098.full.pdf - Published Version
Download (307kB) | Preview

Type:	Article
Title:	Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?
Location:	United States
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1212/WNL.0000000000004381
Publisher version:	http://doi.org/10.1212/WNL.0000000000004381
Language:	English
Additional information:	This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI:	https://discovery.ucl.ac.uk/id/eprint/1573226

Downloads since deposit

182Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item